Ikarian Capital’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Hold |
157,720
| – | – | 0.04% | 80 |
|
|
2025
Q1 | $205K | Hold |
157,720
| – | – | 0.03% | 97 |
|
|
2024
Q4 | $265K | Sell |
157,720
-142
| -0.1% | -$239 | 0.04% | 99 |
|
|
2024
Q3 | $305K | Hold |
157,862
| – | – | 0.04% | 83 |
|
|
2024
Q2 | $431K | Hold |
157,862
| – | – | 0.08% | 72 |
|
|
2024
Q1 | $453K | Hold |
157,862
| – | – | 0.05% | 69 |
|
|
2023
Q4 | $382K | Hold |
157,862
| – | – | 0.04% | 66 |
|
|
2023
Q3 | $504K | Buy |
157,862
+1,659
| +1% | +$5.29K | 0.06% | 60 |
|
|
2023
Q2 | $341K | Hold |
156,203
| – | – | 0.05% | 64 |
|
|
2023
Q1 | $462K | Hold |
156,203
| – | – | 0.1% | 72 |
|
|
2022
Q4 | $375K | Hold |
156,203
| – | – | 0.09% | 46 |
|
|
2022
Q3 | $437K | Sell |
156,203
-24,996
| -14% | -$69.9K | 0.09% | 50 |
|
|
2022
Q2 | $942K | Hold |
181,199
| – | – | 0.17% | 46 |
|
|
2022
Q1 | $1.23M | Buy |
181,199
+8,890
| +5% | +$60.1K | 0.16% | 60 |
|
|
2021
Q4 | $1.07M | Hold |
172,309
| – | – | 0.16% | 71 |
|
|
2021
Q3 | $1.16M | Sell |
172,309
-2,502
| -1% | -$16.8K | 0.08% | 92 |
|
|
2021
Q2 | $1.2M | Buy |
+174,811
| New | +$1.2M | 0.1% | 104 |
|